Article info
Best Evidence Topic reports
Bet 2: Doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation
Citation
Bet 2: Doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation
Publication history
- First published December 20, 2011.
Online issue publication
October 24, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.